ATC code - N03AG01
PolandValproic acid
-
Form: tablets, prolonged release
Active substance Dosage sodium valproate 300 mg ATC code: N03AG01
Manufacturer: Orion Corporation
-
Form: tablets, prolonged release
Active substance Dosage sodium valproate 500 mg ATC code: N03AG01
Manufacturer: Orion Corporation
-
Form: tablets, prolonged release
Active substance Dosage sodium valproate 300 mg ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Form: capsules, soft gelatin
Active substance Dosage valproic acid 500 mg ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Form: syrup
Active substance Dosage sodium valproate 50 mg/ml valproic acid 4.338 g sodium chloride 0.04 g ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Form: capsules, soft gelatin
Active substance Dosage valproic acid 150 mg ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Form: capsules, soft gelatin
Active substance Dosage valproic acid 300 mg ATC code: N03AG01
Manufacturer: G.L. Pharma GmbH
-
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg/4 ml ATC code: N03AG01
Manufacturer: Sanofi Belgium
-
Form: syrup
Active substance Dosage sodium valproate 5.764 g ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industrie Unither Liquid Manufacturing
-
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC code: N03AG01
Manufacturer: Sanofi s.r.o.
-
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 200 mg valproic acid 87 mg ATC code: N03AG01
Manufacturer: Sanofi Aventis S.A. Sanofi Winthrop Industry
-
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 333 mg valproic acid 145 mg ATC code: N03AG01
Manufacturer: Sanofi-aventis Monoprósopi S.A.
-
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 333 mg valproic acid 145 mg ATC code: N03AG01
Manufacturer: Sanofi-aventis Monoprósopi S.A.
-
Form: granules, prolonged release
Active substance Dosage sodium valproate 66.66 mg valproic acid 29.03 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Form: granules, prolonged release
Active substance Dosage sodium valproate 666.6 mg valproic acid 290.27 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Form: granules, prolonged release
Active substance Dosage sodium valproate 166.76 mg valproic acid 72.61 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Form: granules, prolonged release
Active substance Dosage sodium valproate 333.3 mg valproic acid 145.14 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Form: granules, prolonged release
Active substance Dosage sodium valproate 500.06 mg valproic acid 217.75 mg ATC code: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
Form: tablets, prolonged release
Active substance Dosage valproic acid No input provided sodium valproate No input provided ATC code: N03AG01
Manufacturer: HEXAL A/S Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH
-
Form: tablets, prolonged release
Active substance Dosage valproic acid No input provided sodium valproate No input provided ATC code: N03AG01
Manufacturer: HEXAL A/S Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH